Advanced nanoparticle tracking technology for biomedical research

ZetaView x30 QUATT Multi-Fluorescence Nanoparticle Tracking Analyzer

NIH-funded research University of California, San Diego · NIH-10854023

This study is all about getting a new high-tech tool that helps scientists better understand tiny particles in our bodies that can affect health, and it will be available for researchers at UC San Diego and nearby places to work together on important medical discoveries.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego NIH-funded
Lab location1 site (La Jolla, United States)
Project IDNIH-10854023 on NIH RePORTER

What this research studies

This research focuses on acquiring a state-of-the-art ZetaView® x30 QUATT Multi-Fluorescence Nanoparticle Tracking Analyzer, which will enhance the study of extracellular vesicles and bio-nanoparticles. The analyzer allows researchers to measure various properties of nanoparticles, including size, concentration, and fluorescence, with the unique ability to assess the colocalization of fluorescence signals. This capability is crucial for accurately characterizing different subpopulations of extracellular vesicles, which can lead to significant advancements in understanding various diseases. The instrument will be accessible to researchers at UC San Diego and nearby institutions, promoting collaboration and innovation in multiple biomedical fields.

Who could benefit from this research

Good fit: Ideal candidates for benefiting from this research include patients with conditions related to cancer, diabetes, and other diseases where extracellular vesicles play a critical role.

Not a fit: Patients with conditions unrelated to extracellular vesicles or those not participating in research activities at UC San Diego may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic and therapeutic strategies for diseases such as cancer and diabetes by enhancing our understanding of extracellular vesicles.

How similar studies have performed: Other research has successfully utilized advanced nanoparticle tracking technologies, indicating a promising potential for this approach.

Where this research is happening

La Jolla, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer CenterCancersDiabetes Mellitus
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.